Phenotypic changes and inflammatory cell distribution in the cornea during development of experimental immune-mediated blepharoconjunctivitis

Japanese Journal of Ophthalmology

Volumn 48, Issue 4, 2004, Pages 333-339

  Ozaki, Akemi ^a   Ishida, Waka ^a   Fukata, Kazuyo ^a   Fukushima, Atsuki ^a   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Allergic conjunctivitis; Cornea; Eosinophils; Macrophages; T cells

Indexed keywords

FREUND ADJUVANT; MAJOR BASIC PROTEIN; OVALBUMIN;

ACTIVE IMMUNIZATION; ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEPHAROCONJUNCTIVITIS; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA STROMA; DENDRITIC CELL; DISEASE COURSE; EOSINOPHIL; EXPERIMENTAL INFECTION; IMMUNE MEDIATED INJURY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

EID: 3542991471     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-004-0080-0     Document Type: Article

References (20)

1. Fujishima H, Fukagawa K, Satake Y, et al. Combined medical and surgical treatment of severe vernal keratoconjunctivitis. Jpn J Ophthalmol 2000;44:511-515.
2. Kobayashi A, Nagata A, Shirao Y, et al. Surgical treatment of limbal vernal keratoconjunctivitis by resection of a limbal lesion. Jpn J Ophthalmol 2002;46:679-681.
3. Abu EI-Asrar AM, Meersschaert A, Al-Kharashi SA, Missotten L, Geboes K. Immuno-histochemical evaluation of conjunctival remodelling in vernal keratoconjunctivitis. Eye 2003;6:767-771.
4. Leonardi A, Brun P, Tavolato M, Abatangelo G, Plebani M, Secchi AG. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2000;41:4175-4181.
5. Ebihara N, Okumura K, Nakayasu K, Kanai A, Ra C. High level of Fc epsilon receptor I-bindable immunoglobulin E in the tear fluid and increased immunoglobulin E-saturated cells in the giant papillae of vernal keratoconjunctivitis patients. Jpn J Ophthalmol 2002;46:357-363.
6. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H. Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 1999;18:117-124.
7. Ozaki A, Fukushima A, Fukata K, Ueno H. Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats. Clin Exp Immunol 2000;122:28-34.
8. Ozaki A, Fukushima A, Fukata K, Ueno H. Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2003;241:394-402.
9. Fukushima A, Fukata K, Ozaki A, et al. Exertion of the suppressive effects of IFN-gamma on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol 2002;86:1166-1171.
10. Fukushima A, Ozaki A, Fukata K, Ueno H. Ag-specific recognition, activation and effector function of T cells in the conjunctiva developing experimental immune-mediated blepharoconjunctivitis. Invest Ophthalmol 2003;44:4366-4374.
11. Kawamoto T, Shimizu M. A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol 2000;113:331-339.
12. Messmer EM, May CA, Stefani FH, Welge-Luessen U, Kampik A. Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am J Ophthalmol 2002;134:816-821.
13. Hingorani M, Calder V. Jolly G, Buckley RJ, Lightman SL. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998;102:821-830.
14. Hingorani M, Calder VL, Buckley RJ, Lightman SL. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res 1998;67:491-500.
15. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature 1979;282:320-321.
16. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology 1982;89:700-711.
17. Peerler JS, Niederkorn JY. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocytic responses to alloantigens. J Immunol 1986;136:4362-4371.
18. Streilein JW. Regional immunity and ocular privilege. Chem Immunol 1999;73:11-38.
19. Catry I, Van den Oord M, Foets B, Missotten I. Morphologic and immunophenotypic heterogeneity of corneal dendritic cells. Graefes Arch Clin Exp Ophthalmol 1991;229:182-185.
20. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 2003;44:581-589.